Key Takeaways
- Robotic thyroidectomy carries a reported temporary RLN injury rate of 3.8%–16.0% and permanent injury rate of 0%–0.9% in international series, with high-volume tertiary centers reporting temporary and permanent RLN injury rates of 1.8% and 0.2%, respectively.
- Successful monitoring system setup is confirmed when VN stimulation at 3 mA yields an EMG amplitude >500 μV; failure to achieve this threshold should prompt troubleshooting before dissection begins.
- The standardized four-step protocol (V1, R1, R2, V2) is recommended at Grade A for RLN monitoring, while EBSLN monitoring (S1, S2) is likewise a Grade A recommendation.
- EMG signal is the primary functional reference for RLN, whereas cricothyroid muscle twitch is the primary reference for EBSLN, because EBSLN-evoked EMG is only obtainable in 70%–80% of patients and is unstable.
Clinical Context
The confined operative space of the neck demands precise dissection and meticulous protection of the RLN, EBSLN, VN, and—less commonly—the phrenic nerve, SAN, and brachial plexus during thyroid and parathyroid surgery. Robotic surgical systems offer 3D high-definition magnification and seven degrees of freedom beyond the human wrist, making them a powerful platform for integrating adjunctive technologies. However, the most common mechanisms of nerve injury in robotic thyroid and parathyroid surgery remain technical inexperience, Thermal Injury from energy devices, and Traction Injury arising from the absence of haptic feedback.
Patients electing robotic approaches are frequently young, high-income, or members of voice-dependent professions (teachers, singers, attorneys) with elevated expectations for postoperative voice quality and quality of life. IONM—already widely accepted in open thyroid and parathyroid surgery—can be adapted to the robotic setting, though its application differs in several important respects. This protocol synthesizes the consensus recommendations developed by the Chinese Thyroid Association and affiliated surgical societies to standardize the clinical use of IONM in robotic thyroid and parathyroid procedures.
Clinical Evidence & Cohort Breakdown
The consensus draws on published international and high-volume tertiary center data to frame expected injury rates and the value of monitoring. The table below summarizes reported outcomes and the recommendation grading framework used throughout the protocol.
| Parameter / Outcome | Reported Value | Source Context |
|---|---|---|
| Temporary RLN injury (robotic thyroidectomy) | 3.8%–16.0% | International series |
| Permanent RLN injury (robotic thyroidectomy) | 0%–0.9% | International series |
| Temporary RLN injury | 1.8% | High-volume tertiary center data |
| Permanent RLN injury | 0.2% | High-volume tertiary center data |
| EBSLN-evoked EMG obtainable | 70%–80% of patients | IONM feasibility data |
| VN stimulation threshold for system confirmation | >500 μV at 3 mA | System setup criterion |
| Event threshold (default) | 100 μV | Device parameter |
| Probe stimulation frequency | 4 Hz | Device parameter |
Recommendation grading (per consensus):
| Grade | Meaning |
|---|---|
| A | Strong recommendation; evidence certain, benefit outweighs harm |
| B | Recommendation; good evidence, benefit outweighs harm |
| C | Recommendation based on expert opinion |
| D | Recommendation against, based on expert opinion |
| E | Recommendation against; good evidence, harm outweighs benefit |
| F | Strong recommendation against; evidence certain |
| I | Not recommended / insufficient or conflicting evidence |
Intraoperative IONM Protocol & Technical Pearls
1. Preoperative preparation. Confirm robotic surgical indications and absence of contraindications. Complete electronic laryngoscopy, neck ultrasound, thyroid function, and parathyroid hormone testing; obtain contrast-enhanced neck CT and/or MRI and FNAC for large tumors or suspicious lymph nodes (Grade A). Preoperatively assess thyroid size, upper/lower pole position, tumor location, neck length, and clavicle prominence to guide nerve exposure and monitoring (Grade C). Obtain informed consent covering the purpose and cost of IONM.
2. Anesthesia and airway setup. After positioning, intubate using an IONM-compatible EMG Endotracheal Tube (EMG Tube). Use a 1×ED95 intermediate-acting non-depolarizing neuromuscular blocker for induction only; do not administer additional muscle relaxant intraoperatively to avoid Neuromuscular Blockade (NMB) Residual that suppresses evoked EMG.
3. Electrode and equipment connection. Place the grounding electrode subcutaneously via Subdermal Needle Electrodes—select the site according to approach (subxiphoid, deltoid region, or limb muscle groups). Connect the recording, return, ground, and probe-stimulation leads to the interface box by color coding. Clamp the mute detector onto the electrocautery output line to suppress interference tones.
4. Parameter configuration and system verification. Set the event threshold to 100 μV, probe stimulation frequency to 4 Hz, and default stimulation current to 1–3 mA. After flap elevation, test at 1 mA on anterior neck musculature to confirm delivered current matches the set value. Then stimulate the carotid sheath at 3 mA; a VN-evoked EMG amplitude >500 μV confirms successful system establishment.
5. Select the monitoring method. The direct (percutaneous) method introduces a 16 G needle puncture ~2 cm above the sternoclavicular line at the midline, avoiding anterior neck vessels. It is simple but leaves a scar, compromises cosmesis, requires assistant assistance, and occupies an instrument arm. The indirect method—preferred—attaches needle-, hook-, or clamp-type probes to a current-carrying robotic instrument. Hook- and clamp-type probes are stable and require no assistant. The recommended configuration is a robotic 5 mm dissecting forceps with an exposed metal shaft connected to the probe, enabling real-time, continuous, and point monitoring through any approach without a neck puncture (Grade B).
6. RLN four-step standardized monitoring (V1, R1, R2, V2) — Grade A.
- Step 1 (V1): After adequate exposure, stimulate the VN at the upper and lower pole level of the affected side to confirm system connection and detect NRLN variants. Record V1.
- Step 2 (R1): Dissect the inferior pole vessels close to the gland; elevate the lower pole and use the "cross-intersection" technique at the tracheoesophageal groove to localize the RLN. Record R1.
- Step 3 (R2): Under real-time monitoring, fully dissect and expose the RLN; record R2 at the most proximal exposed segment.
- Step 4 (V2): After hemostasis, re-stimulate the VN and record V2.
- If a large tumor prevents RLN detection at the lower pole, retract the divided upper pole and point-stimulate 0.5–1.0 cm below the inferior cornu of the thyroid cartilage, then dissect top-down under real-time monitoring. For tumor infiltration, dissect the RLN under Continuous IONM (C-IONM).
7. EBSLN standardized monitoring (S1, S2) — Grade A.
- Regional dissection: Bluntly separate the avascular space along the upper pole and retract inferolaterally to expose the sternothyroid–laryngeal triangle and the cricothyroid straight and oblique muscles.
- Localization: Retract the upper pole inferolaterally; stimulate the cricothyroid–laryngeal triangle at 2 mA for initial localization, then refine at the point of maximal EMG response. Routine EBSLN exposure is not advised unless the nerve sits low and is encountered during upper pole management.
- Identification (S1): Before ligating upper pole vessels, stimulate the EBSLN at 1 mA to evoke cricothyroid twitch; record S1. During division, monitor the most proximal exposed segment in real time—if EMG amplitude suddenly weakens or disappears, pause cautery and check for clamping, excessive traction, or Thermal Injury.
- Functional assessment (S2): After upper pole management, re-stimulate at the same current to record S2; for unexposed nerves, use 2 mA suprathreshold probing along the EBSLN course. Both cricothyroid twitch and S2 indicate functional integrity.
8. Stimulation current by nerve. RLN: 2–3 mA; VN: 3–5 mA; EBSLN: 1–2 mA. For phrenic nerve, SAN, and brachial plexus, use 1–2 mA low-current stimulation of the nerve or surrounding tissue, judging course and integrity by muscle twitch—limit duration and repetitions to avoid electrical nerve injury (Grade C).
9. Troubleshooting robotic-specific signal problems. Because indirect monitoring presents a larger tissue contact area, EMG and audio signals may be weaker; increase stimulation current modestly and ensure only the instrument tip contacts the nerve, avoiding current shunting through adjacent tissue (Grade C). The closed robotic field accumulates mist and exudate causing resistance-related signal attenuation—insufflate low-pressure, high-flow CO₂ (0.7–0.9 kPa, 10–15 L/min), place an exhaust port at the instrument arm channel, and use gauze to absorb fluid, keeping the contact surface clean during probing.
Clinical Implications for Surgeons & IONM Specialists
- Anatomical continuity does not equal functional integrity. Loss of Signal (LOS) in R2 or V2 does not by itself confirm nerve injury; always exclude equipment failure, anesthetic effects, and poor electrode contact before interpreting a True-Positive LOS.
- Match the functional reference to the nerve. Use EMG as the primary RLN reference and cricothyroid twitch as the primary EBSLN reference; EBSLN EMG has a short Latency (ms), poor stability, and high variability.
- Integrate dissection and monitoring. The 5 mm forceps–probe configuration achieves "dissection–monitoring integration," enabling precise navigation, risk warning, and prevention of mechanical and Thermal Injury while shortening operative time—particularly valuable for less experienced surgeons, parathyroid procedures, and complex thyroid cases.
- Confirm postoperative function with laryngoscopy. Compare postoperative vocal cord motion against preoperative video to determine whether Vocal Cord Paralysis (VCP) is surgery-related.
- Standardize to reduce variability. Persistent issues in robotic IONM include inconsistent methods, weak technique, and low utilization; adherence to the V1–R1–R2–V2 and S1–S2 frameworks improves reproducibility and safety.
Reference
Chinese Thyroid Association, Chinese Medical Doctor Association; Thyroid Disease Professional Committee, Chinese Research Hospital Association; Clinical Practical Technology Branch, China International Exchange and Promotive Association for Medical and Health Care; Thyroid Surgery Equipment Committee, Surgical Equipment Branch, China Association of Medical Equipment. Expert consensus on clinical application of intraoperative neurophysiological monitoring in robotic thyroid and parathyroid surgery (2019 edition). Chinese Journal of Practical Surgery. 2019;39(12):1248-1253. DOI: 10.19538/j.cjps.issn1005-2208.2019.12.02.
Medical Disclaimer: This article is provided for informational and educational purposes only and does not constitute medical advice. Clinical decisions regarding intraoperative neuromonitoring, surgical technique, and patient management should be made by qualified healthcare professionals based on individual patient circumstances and institutional protocols. The summarized consensus recommendations reflect the source publication and should be interpreted alongside current international standards and local regulatory requirements.